Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cigna Corp (NY: CI )

276.92 +2.12 (+0.77%)
Official Closing Price Updated: 7:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cigna Corp

< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
NYSE:CI is showing good growth, while it is not too expensive.
For those who appreciate growth without the sticker shock, THE CIGNA GROUP (NYSE:CI) is worth considering. 
Via Chartmill
Are CVS Health, Cigna, and UnitedHealth Group Stocks Bad News Buys With the FTC's PBM Crackdown?
The FTC is going after these PBMs. Is this an opportunity for investors? 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $12,000 Today
Via Benzinga
UnitedHealth Vs. CVS Vs. Cigna: Which Health Stock Will Beat The FTC's Regulatory Heat?
Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices. 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Ready for Open Enrollment? 4 Tips for Choosing the Right Medicare Plan
Via StatePoint Media
(CI) - Analyzing Cigna's Short Interest
Via Benzinga
Here's How Much You Would Have Made Owning Cigna Stock In The Last 10 Years
Via Benzinga
Beyond The Numbers: 8 Analysts Discuss Cigna Stock
Via Benzinga
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
FTC files a complaint against CVS, Cigna, and UnitedHealth's PBMs, accusing them of inflating insulin prices through a rebate-driven system. The case aims to address unfair practices and improve access... 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amgen's Amjevita, in a move aimed at cutting prescription costs. 
Via Benzinga
PayMedix/TempoPay Names David Kinsey Vice President of Sales
Accomplished Healthcare and Sales Executive to Join Expanding Team 
Via News Direct
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Cigna Group Stock Flashing Renewed Technical Strength
The Relative Strength (RS) Rating for Cigna Group stock entered a new percentile Thursday, with a rise from 74 to 81. 
Via Investor's Business Daily
Here's How Much $1000 Invested In Cigna 5 Years Ago Would Be Worth Today
Via Benzinga
Expert Ratings For Cigna
Via Benzinga
Down About 65% in 2024, Is Walgreens Stock a Buy on the Dip?
Shares of the dividend-paying pharmacy chain have been offering a double-digit yield percentage. 
Via The Motley Fool
NYSE:CI is showing decent growth, but is still valued reasonably.
THE CIGNA GROUP (NYSE:CI) is showing decent growth, but is still valued reasonably. 
Via Chartmill
The 3 Best Bargain Stocks to Buy in August 2024
Take advantage of the ongoing correction and buy these three best bargain stocks under 14 times forward earnings. 
Via InvestorPlace
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $16,000 Today
Via Benzinga
Medical Technology Stock Benefits from Rising Acute Care Demand
Medical and surgical products manufacturer Stryker Co. (NYSE: SYK) is a beneficiary of the acute care boom occurring in the healthcare industry. 
Via MarketBeat
Topics Supply Chain
Exposures Supply Chain
How Is The Market Feeling About Cigna?
Via Benzinga
Beyond The Numbers: 6 Analysts Discuss Cigna Group Stock
Via Benzinga
US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday?
Markets experienced a sharp downturn, driven by heightened geopolitical tensions and economic uncertainties that negatively impacted investor risk sentiment, just a day after the Federal Open Market... 
Via Benzinga
Cigna's Q2 Profit Beats Analyst Estimates As Evernorth Health Services Growth Builds Momentum, Reiterates Annual Outlook
Cigna reported Q2 sales of $60.52 billion, up 25% YoY, beating estimates. Growth was driven by Evernorth Health Services' client wins. Adjusted income rose 5% to $1.91 billion. Cigna Healthcare sales... 
Via Benzinga
Cigna Group (CI) Q2 2024 Earnings Call Transcript
CI earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November
After Wednesday’s tech-led rebound amid the Federal Reserve’s rate decision, the stock market could be in for further gains. The major index futures point to a higher opening, although suggesting a... 
Via Benzinga
NYSE:CI is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
THE CIGNA GROUP (NYSE:CI) appears to be flying under the radar despite its strong fundamentals. 
Via Chartmill
Healthy Profits: 7 Healthcare Stocks to Build a Lifetime of Wealth
Healthcare stocks offer wealth to investors through a mix of steady performance, growth and income not to be overlooked. 
Via InvestorPlace
3 Healthcare Stocks to Buy at a 52-Week Low in July
At their 52-week lows, these undervalued healthcare stocks present a favorable return supported by healthcare spending tailwinds. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.